Shree Ganesh Remedies Limited - Laporan Laba Rugi (TTM)

Shree Ganesh Remedies Limited
IN ˙ BSE
₹ 731.70 ↓ -9.75 (-1.31%)
2025-04-28
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Shree Ganesh Remedies Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 529 499 491 515 582 661 713 763 806 815 902 993 1,115 1,174 1,259 1,240 1,229 1,220 1,086 1,085
Change (%) -5.56 -1.67 4.91 13.10 13.50 7.85 7.02 5.62 1.08 10.77 10.07 12.24 5.36 7.20 -1.54 -0.87 -0.75 -10.95 -0.10
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 266 243 222 238 281 325 373 398 419 432 476 521 599 604 582 519 480 439 391 362
Change (%) -8.78 -8.43 7.02 18.14 15.64 14.89 6.64 5.32 2.99 10.40 9.39 14.88 0.80 -3.49 -10.85 -7.64 -8.51 -10.79 -7.48
% of Revenue 50.31 48.60 45.25 46.17 48.22 49.13 52.34 52.15 52.00 52.99 52.81 52.48 53.72 51.39 46.26 41.89 39.03 35.98 36.04 33.38
Gross Operating Profit 263 257 269 277 302 336 340 365 387 383 426 472 516 571 677 720 749 781 695 723
Change (%) -2.29 4.73 3.16 8.78 11.51 1.04 7.44 5.95 -1.00 11.18 10.83 9.33 10.66 18.52 6.47 4.01 4.22 -11.04 4.06
% of Revenue 49.69 51.40 54.75 53.83 51.78 50.87 47.66 47.85 48.00 47.01 47.19 47.52 46.28 48.61 53.74 58.11 60.97 64.02 63.96 66.62
SG&A 74 56 73 74 76 78 48 51 71 74 70 61 78 82 98 92 110 116 117 105
Change (%) -23.96 30.58 1.81 2.45 2.31 -37.86 5.23 39.07 4.71 -5.83 -12.97 27.76 5.46 19.08 -6.14 19.97 5.59 1.01 -10.76
% of Revenue 13.93 11.21 14.89 14.45 13.09 11.80 6.80 6.68 8.80 9.12 7.75 6.13 6.98 6.98 7.76 7.39 8.95 9.52 10.80 9.65
R&D
Change (%)
% of Revenue
OpEx 426 398 378 400 453 513 562 605 632 645 697 774 851 892 896 879 851 833 778 801
Change (%) -6.64 -5.01 5.79 13.20 13.35 9.51 7.66 4.43 1.99 8.19 11.04 9.89 4.77 0.47 -1.88 -3.16 -2.11 -6.68 2.97
% of Revenue 80.70 79.77 77.06 77.70 77.77 77.66 78.86 79.33 78.43 79.14 77.30 77.99 76.36 75.92 71.16 70.91 69.27 68.33 71.60 73.81
Operating Income 102 101 113 115 129 148 151 158 174 170 205 219 264 283 363 361 378 386 308 284
Change (%) -1.03 11.53 1.95 12.77 14.04 2.08 4.64 10.21 -2.26 20.54 6.74 20.56 7.28 28.44 -0.71 4.71 2.31 -20.15 -7.86
% of Revenue 19.30 20.23 22.94 22.30 22.23 22.34 21.14 20.67 21.57 20.86 22.70 22.01 23.64 24.08 28.84 29.09 30.73 31.67 28.40 26.19
Interest Expense -37,674 -0 -1 -1 -1 -1 -3 -1 -1 -0 -0 -0 -5 -9 -13 -16 -20 -27
Change (%) -100.00 172.08 12.33 15.50 -2.25 154.81 -79.46 -8.56 -11.16 -63.64 8,988.33 68.55 39.56 28.60 22.01 35.57
% of Revenue -7,547.69 -0.06 -0.16 -0.16 -0.16 -0.15 -0.35 -0.07 -0.06 -0.05 -0.01 -0.01 -0.43 -0.74 -1.04 -1.35 -1.85 -2.52
Net Income 92 94 98 101 112 126 134 139 148 150 170 189 215 220 281 280 279 285 231 219
Change (%) 1.36 4.15 3.73 10.32 12.82 6.40 3.95 6.59 1.00 13.52 11.07 13.85 2.15 27.86 -0.36 -0.53 2.19 -18.97 -5.22
% of Revenue 17.48 18.76 19.87 19.65 19.17 19.05 18.80 18.26 18.42 18.41 18.87 19.04 19.31 18.72 22.33 22.59 22.67 23.34 21.24 20.15

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista